Skip to main content
Clinical Trials/RBR-5s234bn
RBR-5s234bn
Not yet recruiting
未知

Acute and chronic effect of motor and non-motor intervention on gait asymmetry in patients with Parkinson's disease

niversidade Estadual Paulista Júlio de Mesquita Filho0 sitesMay 28, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversidade Estadual Paulista Júlio de Mesquita Filho
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 28, 2024
End Date
December 15, 2026
Last Updated
last year
Study Type
Intervention

Investigators

Sponsor
niversidade Estadual Paulista Júlio de Mesquita Filho

Eligibility Criteria

Inclusion Criteria

  • For participants of the Parkinson group: have a minimum age of 50 and a maximum of 80 years; both genders; having a diagnosis by a private neurologist that indicates the presence of Idiopathic Parkinson Disease; have independent locomotion without the aid of auxiliary devices (cane, for example); being under drug treatment with stable levodopa for at least 3 weeks; not having undergone brain surgery or deep brain stimulation for Parkinson Disease treatment; no history of orthopedic and vision problems that make it impossible to comply with the experimental protocol (corrected vision with glasses is allowed); not having uncontrolled cardiovascular, metabolic or inflammatory problems; not showing advanced cognitive decline; present a medical certificate authorizing the performance of physical exercise. For control group participants: have a minimum age of 50 and a maximum of 80 years; both genders; independent locomotion without aid of auxiliary devices; not having history of orthopedic and vision problems that make it impossible to comply with the experimental protocol (corrected vision with glasses is allowed); not having uncontrolled cardiovascular, metabolic or inflammatory problems; not showing advanced cognitive decline

Exclusion Criteria

  • Do not present proof of Parkinson's disease, only for participants in the Parkinson's group in interventions 1 and 3; those with other neurological disorders; heart problems (i.e., arrhythmias, indication of myocardial ischemia); musculoskeletal disorders; cognitive deficits; brain surgery or Deep Brain Stimulation for the treatment of Parkinson disease

Outcomes

Primary Outcomes

Not specified

Similar Trials